絞り込み

16645

広告

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.

著者 Law BJ , Langley JM , Allen U , Paes B , Lee DS , Mitchell I , Sampalis J , Walti H , Robinson J , O'Brien K , Majaesic C , Caouette G , Frenette L , Le Saux N , Simmons B , Moisiuk S , Sankaran K , Ojah C , Singh AJ , Lebel MH , Bacheyie GS , Onyett H ,
Pediatr Infect Dis J.2004 Sep ; 23(9):806-14.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Department of Pediatrics and Child Health, University of Manitoba and the Winnipeg Health Sciences Center, Winnipeg, Canada. blaw@ms.umanitoba.ca

スターを付ける スターを付ける     (61view , 0users)

Full Text Sources

Medical

Miscellaneous

Infants born at 33 through 35 completed weeks of gestation (33-35GA) are at risk for severe respiratory syncytial virus (RSV) infection, and palivizumab prophylaxis lowers hospitalizations for RSV infection by as much as 80%. The 33-35GA cohort comprises 3-5% of annual births; thus expert panels recommend limiting prophylaxis to situations in which frequency or health care impact of RSV infection is high. This study sought to identify independent risk factors for hospitalization for RSV infection.
PMID: 15361717 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード